BioLight Life Sciences Ltd. (TLV:BOLT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
665.00
-27.30 (-3.94%)
Feb 20, 2025, 5:24 PM IDT
38.98%
Market Cap 32.22M
Revenue (ttm) 198.00K
Net Income (ttm) -6.16M
Shares Out 4.66M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7
Average Volume 1,265
Open 692.30
Previous Close 692.30
Day's Range 665.00 - 692.30
52-Week Range 4.40 - 702.00
Beta 0.58
RSI 66.93
Earnings Date Mar 22, 2025

About BioLight Life Sciences

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company’s ophthalmic product offering and pipeline of product candidates include DiagnosTear’s TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival imp... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BOLT
Full Company Profile

Financial Performance

In 2023, BioLight Life Sciences's revenue was 118,000, an increase of 87.30% compared to the previous year's 63,000. Losses were -26.02 million, 231.6% more than in 2022.

Financial Statements

News

There is no news available yet.